Arthritis News and Research

Latest Arthritis News and Research

AMG 386 demonstrates antitumor activity in Phase 2 trial involving patients with recurrent ovarian cancer

AMG 386 demonstrates antitumor activity in Phase 2 trial involving patients with recurrent ovarian cancer

Eisai's eribulin mesylate improves median OS compared with TPC in pre-treated metastatic breast cancer patients

Eisai's eribulin mesylate improves median OS compared with TPC in pre-treated metastatic breast cancer patients

Phase 3 trial demonstrates superiority of Amgen's denosumab over Zometa in preventing SREs

Phase 3 trial demonstrates superiority of Amgen's denosumab over Zometa in preventing SREs

Vitiligo is associated with variations in genes that play role in body's natural defenses: Scientists

Vitiligo is associated with variations in genes that play role in body's natural defenses: Scientists

Plexxikon announces Phase 1 extension study results of PLX4032 in metastatic colorectal cancer

Plexxikon announces Phase 1 extension study results of PLX4032 in metastatic colorectal cancer

Positive results from new analyses of denosumab Phase 3 trials

Positive results from new analyses of denosumab Phase 3 trials

Researchers one step closer to understand how activity outside of nucleus determines cell's behavior

Researchers one step closer to understand how activity outside of nucleus determines cell's behavior

Amgen to present Phase 2 study data of AMG 479 in metastatic pancreatic cancer at 2010 ASCO

Amgen to present Phase 2 study data of AMG 479 in metastatic pancreatic cancer at 2010 ASCO

Study provides personalized strategies to boost AIAA compliance in breast cancer patients

Study provides personalized strategies to boost AIAA compliance in breast cancer patients

New approach to treat RA can change lives of millions of patients: Research

New approach to treat RA can change lives of millions of patients: Research

Total ankle replacement surgery available as option for patients with painful arthritis: ACFAS

Total ankle replacement surgery available as option for patients with painful arthritis: ACFAS

Entelos' T1D PhysioLab platform published in Clinical and Experimental Immunology

Entelos' T1D PhysioLab platform published in Clinical and Experimental Immunology

Meditation-based therapies benefit patients with chronic pain

Meditation-based therapies benefit patients with chronic pain

Researchers develop new technique to detect cathepsin K in atherosclerosis, cancer metastasis

Researchers develop new technique to detect cathepsin K in atherosclerosis, cancer metastasis

Genes influence AIAA side effect in breast cancer survivors

Genes influence AIAA side effect in breast cancer survivors

Excess levels of a protein associated with TNF may produce cognitive decline: Studies

Excess levels of a protein associated with TNF may produce cognitive decline: Studies

Medicare patients may face accessibility crisis to medical care

Medicare patients may face accessibility crisis to medical care

Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteoporosis

Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteoporosis

FDA approves Prolia for postmenopausal women with osteoporosis

FDA approves Prolia for postmenopausal women with osteoporosis

BioCryst to commence Phase 2 study of BCX4208 alone and in combination with allopurinol in gout patients

BioCryst to commence Phase 2 study of BCX4208 alone and in combination with allopurinol in gout patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.